Single-cell functional omics.
Truly precise medicine.
Our technology and applications enable improved targeting of complex treatments to the patients who need them most. By isolating single patient cells and detecting their omic, or full, end function, the IsoPlexis precision engineering platform – developed by scientific leaders at Yale and Cal Tech – can offer breakthrough clinical insights.
The IsoPlexis IsoCode readout captures the omic, or full, end function from thousands of single cells in parallel to better understand complex patient response. The IsoCode chip, recognized in the literature as the SCBC, has been well validated in various immune and cancer detection applications, and has been making breakthroughs with UCLA, Memorial Sloan Kettering, and more.
Applications to precision medicine in areas of highly complex patient activity